28 August 2012
Postrenal transplant renopulmonary zygomycosis with vascular aneurysms responded to surgical treatment and salvage therapy with posaconazole after failure to respond to liposomal amphoterici
Zaina Al Maskari, Faryal Al LawatiaDOI: 10.12659/AJCR.883333
Am J Case Rep 2012; 13:202-205
Abstract
Background: Zygomycosis is a difficult to treat and frequently fatal infection affecting immunocompromised and (rarely) immunocompetent patients. It requires a multifaceted approach involving elimination of predisposing factors, surgical debridement, and antifungal therapy.
Case Report: We report the case of a postrenal transplant patient who developed disseminated zygomycosis with vascular aneurysms after receiving empirical voriconazole treatment for presumed pulmonary fungal infection in addition to immunosuppression and methylprednisolone pulses for presumed graft rejection, as renal biopsy was declined. Initially, liposomal amphotericin therapy in combination with surgical intervention failed. Addition of posaconazole as salvage therapy improved the patient outcome. He received total of 6 weeks of AmBisome and 12 weeks of posaconazole.
Conclusions: Zygomycosis is a difficult to treat infection. Management includes surgical debridement and antifungal therapy, namely liposomal amphotericin. However, in cases where treatment with liposomal amphotericin along with surgical intervention fails, posaconazole can be given as a salvage therapy. Duration of antifungal treatment should be determined on an individual basis.
Keywords: Renopulmonary, Zygomycosis, postrenal transplant, posaconazole therapy
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946956
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946875
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947289
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946614
Most Viewed Current Articles
21 Jun 2024 : Case report
95,940
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
52,046
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
30,832
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,344
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030